生物正交化学
化学
肿瘤缺氧
生物化学
催化作用
组合化学
体内
康布雷他汀
肿瘤微环境
细胞内
细胞生物学
生物物理学
癌症治疗
癌细胞
作者
Lili Xia,Xiangxuan Chao,Zitong Zhao,Xiaozhen Zhou,Chenyao Wu,Xinran Song,Wenli Zhou,Yuyao Li,Wei Feng,Yu Chen
出处
期刊:ACS Nano
[American Chemical Society]
日期:2026-08-20
卷期号:20 (34): 23975-23991
标识
DOI:10.1021/acsnano.6c08698
摘要
Bioorthogonal chemistry provides a compelling strategy for in situ cytotoxin generation. However, the clinical translation of conventional bioorthogonal catalysts is impeded by poor tumor accumulation, insufficient targeting specificity, limited in vivo catalytic efficiency, and inadequate spatiotemporal control. Meanwhile, excessive lactate accumulation in the tumor microenvironment (TME) drives metabolic reprogramming, malignant progression, and therapeutic resistance. Here, we develop a living bacterial hybrid reactor by integratingShewanella oneidensis MR-1 (S.o) with Cu(II)-based zeolitic imidazolate frameworks to enable metabolism-guided and tumor-confined bioorthogonal catalysis. Exploiting the intrinsic hypoxia tropism of S.o, the hybrid reactor selectively accumulates within the TME. In the lactate-rich tumor, endogenous lactate drives bacterial reduction of inert Cu(II) to active Cu(I), enabling in situ catalyst activation and concurrent lactate depletion. The generated Cu(I) catalyzes a localized azide-alkyne cycloaddition between systemically administered prodrugs, producing a combretastatin A-4-like cytotoxin. Simultaneously, intracellular Cu(I) overload induces cuproptosis, while lactate depletion disrupts tumor metabolic homeostasis, together eliciting a synergistic triple antitumor effect. This work establishes a generalizable paradigm in which living bacterial vectors function as both tumor-targeting carriers and self-sustaining biochemical reactors, overcoming key limitations of conventional bioorthogonal catalysis and enabling precise, tumor-confined therapeutic activation.
科研通智能强力驱动
Strongly Powered by AbleSci AI